A nuanced view of extrapleural pneumonectomy for malignant pleural mesotheliomaMultimodality treatment including macroscopic complete resection (MCR) is currently the most effective therapy for patients with malignant pleural mesothelioma (MPM)....
Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know†... During the 2013 ESTS Annual Meeting, different experts of the field presented the current knowledge about diagnostic and prognostic biomarkers in malignant pleural mesothelioma including new perspectives as well as the role and potential application of microRNA and genomic sequencing for lung cancer, which are summarized in the present...
Micrornas for the diagnosis and management of malignant pleural mesothelioma: a literature reviewMalignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a variable incidence among different countries....
Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma.PURPOSE: Multimodality therapy has been applied to resectable malignant pleural mesothelioma, but the tolerability of the treatment and relapse pattern in detail remain unknown....